<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9875924</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">36334274</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9875924</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1002/hbm.26139</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">HBM26139</article-id></all-ids><extracted-table><table-id>hbm26139-tbl-0001</table-id><table-label>TABLE 1</table-label><table-caption>Demographic and clinical information of the participants</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="hbm26139-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Demographic and clinical information of the participants</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristics</th><th align="left" valign="bottom" rowspan="1" colspan="1">PD group</th><th align="left" valign="bottom" rowspan="1" colspan="1">HC group</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic>‐value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="left" valign="top" rowspan="1" colspan="1">61.70 ± 8.47</td><td align="left" valign="top" rowspan="1" colspan="1">59.94 ± 8.65</td><td align="left" valign="top" rowspan="1" colspan="1">.226</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender, male/female</td><td align="left" valign="top" rowspan="1" colspan="1">34/36</td><td align="left" valign="top" rowspan="1" colspan="1">30/40</td><td align="left" valign="top" rowspan="1" colspan="1">.141</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education, years</td><td align="left" valign="top" rowspan="1" colspan="1">11.21 ± 3.65</td><td align="left" valign="top" rowspan="1" colspan="1">12.13 ± 3.68</td><td align="left" valign="top" rowspan="1" colspan="1">.611</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Motor symptoms</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Disease duration, years</td><td align="left" valign="top" rowspan="1" colspan="1">4.50 ± 4.11</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">—</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Hoehn–Yahr stage</td><td align="left" valign="top" rowspan="1" colspan="1">1.73 ± 0.58</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">—</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MDS‐UPDRS III</td><td align="left" valign="top" rowspan="1" colspan="1">27.63 ± 11.99</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">—</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">LEDD, mg</td><td align="left" valign="top" rowspan="1" colspan="1">384.13 ± 294.33</td><td align="left" valign="top" rowspan="1" colspan="1">—</td><td align="left" valign="top" rowspan="1" colspan="1">—</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nonmotor symptoms</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">BSIT</td><td align="left" valign="top" rowspan="1" colspan="1">6.80 ± 2.74</td><td align="left" valign="top" rowspan="1" colspan="1">8.91 ± 2.64</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>.000</bold></td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MoCA</td><td align="left" valign="top" rowspan="1" colspan="1">22.99 ± 3.81</td><td align="left" valign="top" rowspan="1" colspan="1">25.84 ± 2.96</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>.000</bold></td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">RBD‐HK</td><td align="left" valign="top" rowspan="1" colspan="1">21.69 ± 16.55</td><td align="left" valign="top" rowspan="1" colspan="1">9.80 ± 7.17</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>.000</bold></td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Epworth sleepiness scale</td><td align="left" valign="top" rowspan="1" colspan="1">5.44 ± 4.46</td><td align="left" valign="top" rowspan="1" colspan="1">4.39 ± 2.92</td><td align="left" valign="top" rowspan="1" colspan="1">.099</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">HAMD</td><td align="left" valign="top" rowspan="1" colspan="1">6.74 ± 4.81</td><td align="left" valign="top" rowspan="1" colspan="1">0.89 ± 1.80</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>.000</bold></td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">STAI</td><td align="left" valign="top" rowspan="1" colspan="1">71.29 ± 18.52</td><td align="left" valign="top" rowspan="1" colspan="1">54.01 ± 7.89</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>.000</bold></td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">AES‐S</td><td align="left" valign="top" rowspan="1" colspan="1">13.33 ± 8.86</td><td align="left" valign="top" rowspan="1" colspan="1">4.73 ± 4.80</td><td align="left" valign="top" rowspan="1" colspan="1"><bold>.000</bold></td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Pain (UPDRS I‐1.9)</td><td align="left" valign="top" rowspan="1" colspan="1">0.60 ± 0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.19 ± 0.40<xref rid="hbm26139-note-0003" ref-type="table-fn"><sup>a</sup></xref></td><td align="left" valign="top" rowspan="1" colspan="1"><bold>.007</bold></td></tr></tbody></table><table-wrap-foot id="hbm26139-ntgp-0001"><fn id="hbm26139-note-0001"><p><italic toggle="yes">Note</italic>: Values are presented as mean ± standard deviation (SD). Bold values indicate significant differences between two groups.</p></fn><fn id="hbm26139-note-0002"><p>Abbreviations: AES‐S, Apathy Evaluation Scale self‐rated version; BSIT, Brief Smell Identification Test; HAMD, Hamilton Depression Scale; HC, healthy controls; LEDD, levodopa‐equivalent daily dose; MoCA, Montreal Cognitive Assessment; PD, Parkinson's disease; RBD‐HK, Rapid eye movement sleep Behavior Disorder Questionnaire (Hong Kong version); STAI, State‐Trait Anxiety Inventory.</p></fn><fn id="hbm26139-note-0003"><label><sup>a</sup></label><p>16 HC rated MDS UPDRS I and II. Values were derived from 16 HC.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical information of the participants</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">Characteristics</th><th align="left" valign="bottom">PD group</th><th align="left" valign="bottom">HC group</th><th align="left" valign="bottom">p‐value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">Age, years</td><td align="left" valign="top">61.70 ± 8.47</td><td align="left" valign="top">59.94 ± 8.65</td><td align="left" valign="top">.226</td></tr><tr><td align="left" valign="top">Gender, male/female</td><td align="left" valign="top">34/36</td><td align="left" valign="top">30/40</td><td align="left" valign="top">.141</td></tr><tr><td align="left" valign="top">Education, years</td><td align="left" valign="top">11.21 ± 3.65</td><td align="left" valign="top">12.13 ± 3.68</td><td align="left" valign="top">.611</td></tr><tr><td align="left" valign="top">Motor symptoms</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td style="padding-left:10%" align="left" valign="top">Disease duration, years</td><td align="left" valign="top">4.50 ± 4.11</td><td align="left" valign="top">—</td><td align="left" valign="top">—</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Hoehn–Yahr stage</td><td align="left" valign="top">1.73 ± 0.58</td><td align="left" valign="top">—</td><td align="left" valign="top">—</td></tr><tr><td style="padding-left:10%" align="left" valign="top">MDS‐UPDRS III</td><td align="left" valign="top">27.63 ± 11.99</td><td align="left" valign="top">—</td><td align="left" valign="top">—</td></tr><tr><td style="padding-left:10%" align="left" valign="top">LEDD, mg</td><td align="left" valign="top">384.13 ± 294.33</td><td align="left" valign="top">—</td><td align="left" valign="top">—</td></tr><tr><td align="left" valign="top">Nonmotor symptoms</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td style="padding-left:10%" align="left" valign="top">BSIT</td><td align="left" valign="top">6.80 ± 2.74</td><td align="left" valign="top">8.91 ± 2.64</td><td align="left" valign="top">.000</td></tr><tr><td style="padding-left:10%" align="left" valign="top">MoCA</td><td align="left" valign="top">22.99 ± 3.81</td><td align="left" valign="top">25.84 ± 2.96</td><td align="left" valign="top">.000</td></tr><tr><td style="padding-left:10%" align="left" valign="top">RBD‐HK</td><td align="left" valign="top">21.69 ± 16.55</td><td align="left" valign="top">9.80 ± 7.17</td><td align="left" valign="top">.000</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Epworth sleepiness scale</td><td align="left" valign="top">5.44 ± 4.46</td><td align="left" valign="top">4.39 ± 2.92</td><td align="left" valign="top">.099</td></tr><tr><td style="padding-left:10%" align="left" valign="top">HAMD</td><td align="left" valign="top">6.74 ± 4.81</td><td align="left" valign="top">0.89 ± 1.80</td><td align="left" valign="top">.000</td></tr><tr><td style="padding-left:10%" align="left" valign="top">STAI</td><td align="left" valign="top">71.29 ± 18.52</td><td align="left" valign="top">54.01 ± 7.89</td><td align="left" valign="top">.000</td></tr><tr><td style="padding-left:10%" align="left" valign="top">AES‐S</td><td align="left" valign="top">13.33 ± 8.86</td><td align="left" valign="top">4.73 ± 4.80</td><td align="left" valign="top">.000</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Pain (UPDRS I‐1.9)</td><td align="left" valign="top">0.60 ± 0.89</td><td align="left" valign="top">0.19 ± 0.40???</td><td align="left" valign="top">.007</td></tr></tbody></table></div>Note: Values are presented as mean ± standard deviation (SD). Bold values indicate significant differences between two groups.Abbreviations: AES‐S, Apathy Evaluation Scale self‐rated version; BSIT, Brief Smell Identification Test; HAMD, Hamilton Depression Scale; HC, healthy controls; LEDD, levodopa‐equivalent daily dose; MoCA, Montreal Cognitive Assessment; PD, Parkinson's disease; RBD‐HK, Rapid eye movement sleep Behavior Disorder Questionnaire (Hong Kong version); STAI, State‐Trait Anxiety Inventory.a16 HC rated MDS UPDRS I and II. Values were derived from 16 HC.</transformed-table></extracted-table><extracted-table><table-id>hbm26139-tbl-0002</table-id><table-label>TABLE 2</table-label><table-caption>Decreased connectivity with raphe nuclei correlates with motor and nonmotor symptoms in PD</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="hbm26139-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Decreased connectivity with raphe nuclei correlates with motor and nonmotor symptoms in PD</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Clinical variables</th><th align="left" valign="bottom" rowspan="1" colspan="1">Regions with decreased FC</th><th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1">Correlation</th><th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic>‐value</th></tr></thead><tbody valign="top"><tr><td colspan="4" align="left" valign="top" rowspan="1">Dorsal raphe</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Depression (HAMD score)</td><td align="left" valign="top" rowspan="1" colspan="1">Left amygdala</td><td align="left" valign="top" rowspan="1" colspan="1">−0.331</td><td align="left" valign="top" rowspan="1" colspan="1">.005</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Daytime sleepiness (ESS score)</td><td align="left" valign="top" rowspan="1" colspan="1">Left postcentral gyrus</td><td align="left" valign="top" rowspan="1" colspan="1">−0.323</td><td align="left" valign="top" rowspan="1" colspan="1">.006</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Anxiety (STAI score)</td><td align="left" valign="top" rowspan="1" colspan="1">Bilateral cingulate cortex</td><td align="left" valign="top" rowspan="1" colspan="1">−0.296</td><td align="left" valign="top" rowspan="1" colspan="1">.013</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Median raphe</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Motor impairment</td><td align="left" valign="top" rowspan="1" colspan="1">Bilateral pons</td><td align="left" valign="top" rowspan="1" colspan="1">−0.363</td><td align="left" valign="top" rowspan="1" colspan="1">.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">(MDS‐UPDRS III score)</td><td align="left" valign="top" rowspan="1" colspan="1">Left cerebellum</td><td align="left" valign="top" rowspan="1" colspan="1">−0.268</td><td align="left" valign="top" rowspan="1" colspan="1">.025</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Disease severity</td><td align="left" valign="top" rowspan="1" colspan="1">Left cerebellum</td><td align="left" valign="top" rowspan="1" colspan="1">−0.357</td><td align="left" valign="top" rowspan="1" colspan="1">.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">(Hoehn–Yahr stage)</td><td align="left" valign="top" rowspan="1" colspan="1">Left inferior frontal gyrus</td><td align="left" valign="top" rowspan="1" colspan="1">−0.309</td><td align="left" valign="top" rowspan="1" colspan="1">.009</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Left insula</td><td align="left" valign="top" rowspan="1" colspan="1">−0.309</td><td align="left" valign="top" rowspan="1" colspan="1">.009</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Depression (HAMD score)</td><td align="left" valign="top" rowspan="1" colspan="1">Left thalamus</td><td align="left" valign="top" rowspan="1" colspan="1">−0.343</td><td align="left" valign="top" rowspan="1" colspan="1">.004</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cognition (MoCA score)</td><td align="left" valign="top" rowspan="1" colspan="1">Left cerebellum</td><td align="left" valign="top" rowspan="1" colspan="1">0.362</td><td align="left" valign="top" rowspan="1" colspan="1">.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sleep disorder (RBDQ‐HK score)</td><td align="left" valign="top" rowspan="1" colspan="1">Left inferior frontal gyrus</td><td align="left" valign="top" rowspan="1" colspan="1">−0.326</td><td align="left" valign="top" rowspan="1" colspan="1">.006</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Left insula</td><td align="left" valign="top" rowspan="1" colspan="1">−0.326</td><td align="left" valign="top" rowspan="1" colspan="1">.006</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Pain (UPDRS I‐1.9)</td><td align="left" valign="top" rowspan="1" colspan="1">Left superior frontal gyrus</td><td align="left" valign="top" rowspan="1" colspan="1">−0.301</td><td align="left" valign="top" rowspan="1" colspan="1">.011</td></tr></tbody></table></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Decreased connectivity with raphe nuclei correlates with motor and nonmotor symptoms in PD</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">Clinical variables</th><th align="left" valign="bottom">Regions with decreased FC</th><th style="border-bottom:solid 1px #000000" align="left" valign="bottom">Correlation</th><th align="left" valign="bottom">p‐value</th></tr></thead><tbody valign="top"><tr><td colspan="4" align="left" valign="top">Dorsal raphe</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Depression (HAMD score)</td><td align="left" valign="top">Left amygdala</td><td align="left" valign="top">−0.331</td><td align="left" valign="top">.005</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Daytime sleepiness (ESS score)</td><td align="left" valign="top">Left postcentral gyrus</td><td align="left" valign="top">−0.323</td><td align="left" valign="top">.006</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Anxiety (STAI score)</td><td align="left" valign="top">Bilateral cingulate cortex</td><td align="left" valign="top">−0.296</td><td align="left" valign="top">.013</td></tr><tr><td align="left" valign="top">Median raphe</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td style="padding-left:10%" align="left" valign="top">Motor impairment</td><td align="left" valign="top">Bilateral pons</td><td align="left" valign="top">−0.363</td><td align="left" valign="top">.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top">(MDS‐UPDRS III score)</td><td align="left" valign="top">Left cerebellum</td><td align="left" valign="top">−0.268</td><td align="left" valign="top">.025</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Disease severity</td><td align="left" valign="top">Left cerebellum</td><td align="left" valign="top">−0.357</td><td align="left" valign="top">.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top">(Hoehn–Yahr stage)</td><td align="left" valign="top">Left inferior frontal gyrus</td><td align="left" valign="top">−0.309</td><td align="left" valign="top">.009</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Left insula</td><td align="left" valign="top">−0.309</td><td align="left" valign="top">.009</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Depression (HAMD score)</td><td align="left" valign="top">Left thalamus</td><td align="left" valign="top">−0.343</td><td align="left" valign="top">.004</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Cognition (MoCA score)</td><td align="left" valign="top">Left cerebellum</td><td align="left" valign="top">0.362</td><td align="left" valign="top">.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Sleep disorder (RBDQ‐HK score)</td><td align="left" valign="top">Left inferior frontal gyrus</td><td align="left" valign="top">−0.326</td><td align="left" valign="top">.006</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Left insula</td><td align="left" valign="top">−0.326</td><td align="left" valign="top">.006</td></tr><tr><td style="padding-left:10%" align="left" valign="top">Pain (UPDRS I‐1.9)</td><td align="left" valign="top">Left superior frontal gyrus</td><td align="left" valign="top">−0.301</td><td align="left" valign="top">.011</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>